Cyclobenzaprine
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152022This classification denotes a muscle relaxant with the molecular formula C20H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69O5WQQ5TI, chemically known as 10,11-dehydroamitriptyline but generally known as cyclobenzaprine, which bears US NIH Compound Identifier 2895. European Medicines Agency schedules Cyclobenzaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06849MIG. The term CYCLOBENZAPRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules cyclobenzaprine in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOBENZAPRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclobenzaprine under HS 29214980 and SITC 51454. As of Q4 2014, CYCLOBENZAPRINE remains the US FDA Preferred Term for this commodity. Cyclobenzaprine bears US NLM identifiers UMLS ID C0056732 and NCI Concept Code C28947. SMILES: N(CC/C=C1\C2C(C=CC3C1CCCC3)CCCC2)(C)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.